MDGL
Madrigal Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$444.83
+6.10 ▲ +1.39%
🌙 3월 13일 6:38 PM ET (한국 3/14 07:38)
$440.00
-4.83 ▼ -1.09%
| Index | RUT | P/E | - | EPS (ttm) | -12.86 | Insider Own | 9.1% | Shs Outstand | 0.02B | Perf Week | 2.77% |
| Market Cap | 10.20B | Forward P/E | 34.71 | EPS next Y | 380.83% | Insider Trans | -5.98% | Shs Float | 0.02B | Perf Month | -7.52% |
| Enterprise Value | 9.56B | PEG | - | EPS next Q | -4.24 | Inst Own | 103.21% | Short Float | 17.95% | Perf Quarter | -19.48% |
| Income | -0.29B | P/S | 10.65 | EPS this Y | 64.49% | Inst Trans | 1.22% | Short Ratio | 10.68 | Perf Half Y | 1.22% |
| Sales | 0.96B | P/B | 16.86 | EPS next 5Y | - | ROA | -25.05% | Short Interest | 3.74M | Perf YTD | -23.61% |
| Book/sh | 26.39 | P/C | 10.32 | EPS past 3/5Y | 9.32% 0.37% | ROE | -42.49% | 52W High | -27.67% ($615.00) | Perf Year | 37.71% |
| Cash/sh | 43.1 | P/FCF | - | Sales past 3/5Y | - | ROIC | -30.37% | 52W Low | 67.86% ($265.00) | Perf 3Y | 84.72% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 41.81% | Gross Margin | 93.98% | Volatility(W/M) | 3.71% 4.38% | Perf 5Y | 277.49% |
| Dividend TTM | - | EV/Sales | 9.98 | Sales Y/Y TTM | 432.05% | Oper. Margin | -31.31% | ATR (14) | 19.18 | Perf 10Y | 4943.42% |
| Dividend Ex-Date | - | Quick Ratio | 3.77 | EPS Q/Q | 5.3% | Profit Margin | -30.08% | RSI (14) | 45.61 | Recom | 1.29 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.01 | Sales Q/Q | 210.77% | SMA20 | 0.46% ($442.79) | Beta | -0.93 | Target Price | $660.07 |
| Payout | - | Debt/Eq | 0.58 | Earnings | 2000000 | SMA50 | -7.68% ($481.83) | Rel Volume | 0.63 | Prev Close | $438.73 |
| Employees | 915 | LT Debt/Eq | 0.58 | EPS/Sales Surpr. | -187.09% 2.75% | SMA200 | 2.72% ($433.05) | Avg Volume(3M) | 0.35M | Price | $444.83 |
| IPO | 2007/2/6 | Option/Short | Yes/Yes | Trades | 7253 | Volume | 220,755 | Change | 1.39% |
뉴스 로딩 중...